科研之友
微信
新浪微博
Facebook
分享链接
摘要
In 1993, the first disease-modifying therapy (DMT) specifically for relapsing-remitting multiple sclerosis (RRMS) was introduced, and an untreatable disease became treatable. The US Food and Drug Administration now has approved 14 DMTs in 8 classes with different mechanisms of action, administration routes, and side effects.(1) This therapeutic palette allows neurologists to control RRMS in most patients.
- 出版日期2016-7-26
